Login / Signup

De novo truncating variants in PHF21A cause intellectual disability and craniofacial anomalies.

Kohei HamanakaYuji SugawaraTakeyoshi ShimojiTone Irene NordtveitMitsuhiro KatoMitsuko NakashimaHirotomo SaitsuToshimitsu SuzukiKazuhiro YamakawaIngvild AukrustGunnar HougeSatomi MitsuhashiAtsushi TakataKazuhiro IwamaAhmed AlkanaqAtsushi FujitaEri ImagawaTakeshi MizuguchiNoriko MiyakeSatoko MiyatakeNaomichi Matsumoto
Published in: European journal of human genetics : EJHG (2018)
Potocki-Shaffer syndrome (PSS) is a contiguous gene syndrome caused by 11p11.2 deletions. PSS is clinically characterized by intellectual disability, craniofacial anomalies, enlarged parietal foramina, and multiple exostoses. PSS occasionally shows autism spectrum disorder, epilepsy, and overgrowth. Some of the clinical features are thought to be associated with haploinsufficiency of two genes in the 11p11.2 region; variants affecting the function of ALX4 cause enlarged parietal foramina and EXT2 lead to multiple exostoses. However, the remaining clinical features were still yet to be linked to specific genetic alterations. In this study, we identified de novo truncating variants in an 11p11.2 gene, PHF21A, in three cases with intellectual disability and craniofacial anomalies. Among these three cases, autism spectrum disorder was recognized in one case, epilepsy in one case, and overgrowth in two cases. This study shows that PHF21A haploinsufficiency results in intellectual disability and craniofacial anomalies and possibly contributes to susceptibility to autism spectrum disorder, epilepsy, and overgrowth, all of which are PSS features.
Keyphrases
  • intellectual disability
  • autism spectrum disorder
  • copy number
  • attention deficit hyperactivity disorder
  • genome wide
  • working memory
  • case report
  • genome wide analysis